Neurofibroma, Plexiform Clinical Trials

13 clinical trials for Neurofibroma, Plexiform across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... — RECRUITING · PHASE1
• Real-World Treatment Study of Koselugo (Selumetinib) — RECRUITING
• PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas — RECRUITING · PHASE1
• Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1 — RECRUITING · NA
• Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs — ACTIVE_NOT_RECRUITING
• AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) — ACTIVE_NOT_RECRUITING · PHASE1
• Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials — COMPLETED · NA
• Treatment of NF1-related Plexiform Neurofibroma With Trametinib — OTHER · PHASE2
• Study of Imatinib in Children With Neurofibromatosis and Airway Tumors — WITHDRAWN · PHASE2
• Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics — WITHDRAWN
• Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas — COMPLETED · PHASE2
• R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas — COMPLETED · PHASE2

Refine this search